115 W. Century
Rd., Suite 340
We provide specialty
excipients and drug delivery solutions to the health industries worldwide. With
a service and distribution network that spans more than 60 countries, we ensure
responsiveness to the pharmaceutical industry’s needs from both regional and
global perspectives. Gattefossé Corporation serves customers in USA, Canada,
Creating sophisticated and
innovative lipid excipients is a core specialty of the Gattefossé Group. Each
excipient is designed to meet a unique set of formulation and functionality
objectives while conforming to the highest safety, quality, and regulatory
standards. The product offer includes solubilizers, emulsifiers, bioavailability
enhancers, sustained release matrix formers, and skin penetration enhancers for
all routes of administration.
Formulation Development Insight
With the inauguration of
the Application Laboratories in USA, we will support customers with formulation
choices that stand to shorten the development path and improve the solubility,
dissolution, and delivery of molecules. This is over and above our ongoing
efforts that support application of lipids in formulation technologies notably SMEDDS,
Sustained Release, Coatings, Granulation by extrusion or other melt techniques.
Guidance documents for excipient selection and formulation design for
preclinical as well as late development stages are available upon request.
Investing in the USA
This year marks a significant
surge in the Group’s continued investment in the USA that accounts for a 25%
increase in the number of technical and support staff, the construction of a
new, state of the art application laboratory, and expansion of office space at the current
location in Paramus NJ.
The conviction that
achieving an innovative edge benefits all concerned is rooted in the 135 year
history of the Gattefossé enterprise. This vision is supported by continued
investments in research and development and initiatives that foster knowledge sharing.
Sponsoring St-Remy conferences for 50 years and AAPS scientific awards since
1990’s are examples of such initiatives.
Safety, Regulatory & Quality Support
each excipient for physico-chemical properties and safety profiles and ensures
each product has global regulatory acceptance. Every product is supported with
full dossiers including safety data, regulatory standing, and updated Drug Master
Files with the FDA.
We aim to simplify
formulation decisions that minimize attrition rates and shorten the drug
development path. For existing drugs that could benefit from improved dosing,
better patient compliance, or extension of product life cycle, we emphasize innovative
formulation technologies. For new drug entities that suffer from solubility and
bioavailability issues we focus on guidance for pre-formulation decisions that
may be combined with innovative drug delivery approaches.
This record has been viewed 2205